HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

agalsidase alfa

genetically engineered, glycosylated human alpha-galactosidase isoenzyme A used in treatment of Fabry disease; amino acid sequence in first source
Also Known As:
Replagal; TKT Europe brand of agalsidase alfa
Networked: 96 relevant articles (14 outcomes, 23 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Schiffmann, Raphael: 14 articles (11/2015 - 02/2006)
2. Beck, Michael: 12 articles (01/2015 - 06/2002)
3. Beck, M: 11 articles (11/2013 - 01/2003)
4. Ries, Markus: 10 articles (11/2015 - 02/2006)
5. Pastores, Gregory M: 7 articles (01/2014 - 07/2007)
6. Clarke, Joe T R: 7 articles (12/2013 - 08/2005)
7. Mehta, Atul: 7 articles (12/2013 - 06/2002)
8. Mehta, A: 7 articles (12/2009 - 01/2003)
9. Kampmann, Christoph: 6 articles (01/2015 - 09/2006)
10. Sunder-Plassmann, Gere: 6 articles (01/2012 - 01/2006)

Related Diseases

1. Fabry Disease (Fabry's Disease)
2. Pain (Aches)
3. Neuralgia (Stump Neuralgia)
4. Weight Gain
5. Lysosomal Storage Diseases (Lysosomal Storage Disease)

Related Drugs and Biologics

1. agalsidase alfa
2. agalsidase beta
3. globotriaosylceramide (globotriosylceramide)
4. Creatinine
5. imiglucerase (Cerezyme)
6. globotriaosyl lysosphingolipid
7. Lysergic Acid Diethylamide (LSD)
8. Glucosidases
9. alglucerase (Ceredase)
10. alpha-Galactosidase (Beano)

Related Therapies and Procedures

1. Enzyme Replacement Therapy
2. Kidney Transplantation
3. Intravenous Infusions
4. Therapeutics
5. Nebulizers and Vaporizers (Inhaler)